<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The -93G &gt; A (rs1800734) polymorphism within the core promoter region of the MutL homolog 1 (MLH1) gene has recently been proposed as a low penetrance variant for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the significance of rs1800734 on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk by genotyping 10 409 CRC cases and 6965 controls </plain></SENT>
<SENT sid="2" pm="."><plain>The per allele odds ratio (OR) for <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-associated MLH1-93G &gt; A was 1.06 (P = 0.037) </plain></SENT>
<SENT sid="3" pm="."><plain>Using a subset of 3132 cases with known microsatellite instability (MSI) status, the risk was shown to be confined to microsatellite instability-high (MSI-H) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>; OR = 1.39 (P = 1.45 × 10(-4)) </plain></SENT>
<SENT sid="4" pm="."><plain>A meta-analysis of our study and four smaller published studies (totalling 801 cases, 10 890 controls) provided for increased evidence of relationship between MLH1-93G &gt; A and MSI-H <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk (P = 3.43 × 10(-12)) </plain></SENT>
<SENT sid="5" pm="."><plain>The impact of MLH1-93G &gt; A on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> risk was shown to be independent of the 14 low penetrance loci for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> identified by recent genome-wide association studies </plain></SENT>
<SENT sid="6" pm="."><plain>These data provide further evidence that MLH1-93G &gt; A is a low-penetrance variant for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and support the proposition that MLH1-93G &gt; A acts as marker for a somatic event defining a specific <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> subtype </plain></SENT>
</text></document>